Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06494865

" Role of Diffusion Weighted Image in the Diagnosis and Follow up of Breast Cancer"

Breast MRI has become an important tool for breast cancer detection and characterization.Contrast enhanced MRI(CE-MRI) is currently the most sensitive detection technique for diagnosis of breast cancer.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–70 year

Sex eligibility

Female

Study type

Observational

About this study

Most of the lesions that occur in the breast are benign lesions. It is important to recognize benign lesions and distinguish them from breast cancer.

Nowadays sonomammography still represents the primary imaging modality utilized for breast cancer screening and diagnosis.

Breast MRI has become an important tool for breast cancer detection and characterization.Contrast enhanced MRI(CE-MRI) is currently the most sensitive detection technique for diagnosis of breast cancer.Diffusion weighted imaging provides micro-structural informations regadrding the diffusion of the water molecules in the tissue cellularity and tissue structure by using the quantitive analysis with the apparent diffusion coefficient (ADC) values.

Using Diffusion weighted imaging (DWI) combined to MRI is helpful to distinguish malignant versus benign breast lesions and it also may reduce the number of unnecessarily breast biopsies.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • * Female gender
  • Age more than 18 years
  • Patients presented with breast lump
  • Patients with recurrent breast cancer following chemotherapy or radiotherapy sessions.

Exclusion criteria

  • Male gender
  • Age younger than 18 years
  • Patients with recent breast trauma in the same diseased breast within the last 6 months
  • Lactating female presented with acute symptoms as trauma or breast abscess
  • Contraindication to perform MRI examination .these include : Cardiac pacemaker -Metallic aneurysm clips

Treatment and study plan

MRI device

Device

Standered breast coils with small field of veiw and thin sections will be used for the examinatio.

MRI breast including Axial T1WI, T2WI Stir contrast DWI and Stir sagittal T1WI with contrast traction and subtraction

Primary outcomes

  1. Rate of correlated false positive results of MRI DWI for the lesion with the positive results by histopathology.

    Time frame: 6 months

    evaluation of the lesion with MRI DWI and histopathology for detect rate of false posive results

Study contacts

Contact information is provided by the study sponsor or research team.

Medhat I Mohammed, professor

CONTACT

01014005636

Mennatullah A Ibrahim, resident

CONTACT

[email protected]

01015003865

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Jul 10, 2024
Registry last updated
Aug 7, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.